Pfizer: One of the world's premier biopharmaceutical companies
Pfizer: One of the world's premier biopharmaceutical companies. Hope Changes Lives. We’re in relentless pursuit of scientific breakthroughs and revolutionary medicines that will create a healthier world for everyone. Explore Our Science.
Pfizer Inc. (PFE) Stock Price, News, Quote & History - Yahoo Finance
Find the latest Pfizer Inc. (PFE) stock quote, history, news and other vital information to help you with your stock trading and investing.
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full …
2020年12月11日 · COMIRNATY is the first COVID-19 vaccine to be granted FDA approval. Approval is based on a comprehensive submission package including six-month efficacy and safety data after second dose. More than 1.2 billion Pfizer-BioNTech doses have been delivered to more than 120 countries or territories around the world since December 2020.
FDA Approves First COVID-19 Vaccine | FDA - U.S. Food and Drug ...
FDA Office of Media Affairs. 301-796-4540. Consumer: 888-INFO-FDA. FDA approved the first COVID-19 vaccine, which has been known as the Pfizer-BioNTech COVID-19 Vaccine, and is now marketed as ...
Pfizer - Wikipedia
Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology.
Pfizer COVID-19 Vaccine Summary | Vaccines & Immunizations
2024年8月28日 · Pfizer-BioNTech COVID-19 Vaccine is indicated for individuals 5 through 11 years of age (via a 10mcg / 0.3mL single-dose vial presentation) and for individuals 6 months through 4 years of age (via a 3mcg / 0.3mL multi-dose vial (3 doses per vial) presentation).
U.S. FDA Approves Pfizer’s HYMPAVZI™ (marstacimab-hncq) for …
6 天之前 · NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved HYMPAVZI™ (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients 12 years of age and older with hemophilia A (congenital factor VIII …
Pfizer-BioNTech COVID-19 Vaccine | FDA
2023年9月11日 · The Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) is authorized for all doses administered to individuals 6 months through 11 years of age to prevent COVID-19.
A Guide to Pfizer/BioNTech’s COVID-19 Vaccine - FactCheck.org
2024年4月19日 · The Pfizer/BioNTech vaccine is the first COVID-19 vaccine authorized for use in the U.S. and the first to be fully approved by the FDA.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
2020年12月10日 · Effectiveness of Pfizer Vaccine BNT162b2 Against SARS-CoV-2 in Americans 16 and Older: A Systematic Review, Cureus, (2024). https://doi.org/10.7759/cureus.65111